Correlation Between Ultragenyx and Black Diamond

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Ultragenyx and Black Diamond at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ultragenyx and Black Diamond into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ultragenyx and Black Diamond Therapeutics, you can compare the effects of market volatilities on Ultragenyx and Black Diamond and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ultragenyx with a short position of Black Diamond. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ultragenyx and Black Diamond.

Diversification Opportunities for Ultragenyx and Black Diamond

0.79
  Correlation Coefficient

Poor diversification

The 3 months correlation between Ultragenyx and Black is 0.79. Overlapping area represents the amount of risk that can be diversified away by holding Ultragenyx and Black Diamond Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Black Diamond Therap and Ultragenyx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ultragenyx are associated (or correlated) with Black Diamond. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Black Diamond Therap has no effect on the direction of Ultragenyx i.e., Ultragenyx and Black Diamond go up and down completely randomly.

Pair Corralation between Ultragenyx and Black Diamond

Given the investment horizon of 90 days Ultragenyx is expected to generate 3.25 times less return on investment than Black Diamond. But when comparing it to its historical volatility, Ultragenyx is 2.17 times less risky than Black Diamond. It trades about 0.11 of its potential returns per unit of risk. Black Diamond Therapeutics is currently generating about 0.16 of returns per unit of risk over similar time horizon. If you would invest  214.00  in Black Diamond Therapeutics on November 2, 2024 and sell it today you would earn a total of  38.00  from holding Black Diamond Therapeutics or generate 17.76% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Ultragenyx  vs.  Black Diamond Therapeutics

 Performance 
       Timeline  
Ultragenyx 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Ultragenyx has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in March 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.
Black Diamond Therap 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Black Diamond Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Ultragenyx and Black Diamond Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Ultragenyx and Black Diamond

The main advantage of trading using opposite Ultragenyx and Black Diamond positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ultragenyx position performs unexpectedly, Black Diamond can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Black Diamond will offset losses from the drop in Black Diamond's long position.
The idea behind Ultragenyx and Black Diamond Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.

Other Complementary Tools

Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
FinTech Suite
Use AI to screen and filter profitable investment opportunities
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules